Study | Year | Location | Indomethacin (n) | Placebo (n) | Number of PEPs (n) | Intervention | Definition of PEP |
---|---|---|---|---|---|---|---|
Montaño Loza et al. | 2007 | Mexico | 75 | 75 | 16 | 100 mg indomethacin 2 h before ERCP | Pain, Amylase > 3 times |
Sotoudehmane sh et al. | 2007 | Iran-Single centre | 245 | 245 | 22 | 100 mg indomethacin immediately before ERCP | Pain, Amylase > 3 times admission |
Elmunzer et al. | 2012 | US-Multicentre | 295 | 307 | 79 | two 50-mg indomethacin after ERCP | Pain, Amylase > 3 times admission > 2 nigh |
döbrönte et al. | 2014 | Hungary-Multicentre | 347 | 318 | 42 | 100 mg indomethacin 10–15 min before ERCP | Pain, Amylase > 3 times a prolognation of admission, CT/MRI |
Andrade-Dávila et al. | 2015 | Mexico | 82 | 84 | 21 | 100 mg indomenthacin after ERCP | Pain, Amylase > 3 times admission > 2 nigh |
Patai et al. | 2015 | USA-Single centre | 270 | 296 | 55 | 100 mg indomethacin within 1 before ERCP | Pain, Amylase > 3 times |
Levenick et al. | 2016 | USA-Single centre | 223 | 226 | 27 | two 50-mg indomethacin during ERCP | Pain, Amylase > 3 times admission > 2 nigh |